Ea Series Trust Karuna Therapeutics, Inc. Transaction History
Ea Series Trust
- $2.84 Trillion
- Q2 2023
A detailed history of Ea Series Trust transactions in Karuna Therapeutics, Inc. stock. As of the latest transaction made, Ea Series Trust holds 12,839 shares of KRTX stock, worth $0. This represents 0.1% of its overall portfolio holdings.
Number of Shares
12,839Holding current value
$0% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding KRTX
# of Institutions
13Shares Held
333KCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V8213KShares$00.06% of portfolio
-
Tekla Capital Management LLC58.6KShares$00.5% of portfolio
-
International Biotechnology Trust PLC London, X030.5KShares$01.75% of portfolio
-
Brinker Capital Investments, LLC6.1KShares$00.02% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA5KShares$00.01% of portfolio
About Karuna Therapeutics, Inc.
- Ticker KRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,965,000
- Description
- Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...